Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acelrx, Alora, Amplifier, Annji, Avenue, Betagenon, BMS, Cambrian, Defence, Eureka, Exscientia, Hutchmed, Macrogenics, Novo Nordisk, Orano, Synaffix, Takeda, Vesigen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB, Acesion, Akeso, Astellas, Atea, Biohaven, Cantargia, Endo, Gradalis, Immutep, Medivir, Puma, Reneo, Servier, Telix, Tscan.

Biopharmas raising money in public or private financings, including: Myosin, Novan, Onkosxcel, Protai.

New hires and promotions in the biopharma industry, including: Gibson, Proxygen.

Med-tech firms raising money in public or private financings, including: Synaptive Medical.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Akston, Alpha Fusion, Astellas, Biocytogen, Bridgene, Concert, F-star, Hummingbird Bioscience, Invivyd, Invox, Janssen, Johnson & Johnson, Kyorin, Myovant Sciences, Phanes, Pharma15, Radiopharm, Sino, Stelis, Sumitomo, Sumitovant, Sun Pharmaceutical Industries, Takeda, Tessa, Xyphos.

Biopharmas in Asia-Pacific raising money in public or private financings: Allorion, Kyowa Kirin, Opthea, Ring.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astellas, Bioarctic, Eisai, Mesoblast, Revive, Seagen, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Astellas, Astrazeneca, Ausperbio, Bionomics, Biothera Solutions, Daiichi Sankyo, Dyadic, Genfleet, Harbour, Immunovant, Innocare, JW.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cathera, Visby Medical.